arrow
C

Colt A. Egelston

Department of Immuno-Oncology
H指数:19
被引数:1,830

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapy

低级别浆液性卵巢癌患者接受腹腔化疗过程中的差异致癌信号通路和免疫微环境变化

2025-12-140
OAAI
Interim report on engineered NK cell trial in lung cancer refractory to immune checkpoint inhibitors

关于对免疫检查点抑制剂耐药的肺癌患者进行的工程化NK细胞试验的中期报告

2025-02-041
OA
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial
2024-06-1215
OAAI
Oncolytic virus CF33-hNIS for the treatment of advanced cancer
2024-04-050
PRE
CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study
2023-11-101
OAAI
PRELIMINARY RESULTS FROM A PHASE I TRIAL TO EVALUATE INTRAVENTRICULAR DELIVERY OF IL13R.2-TARGETING CAR T CELLS AFTER LYMPHODEPLETION IN PEDIATRIC BRAIN TUMORS PATIENTS
2023-06-120
OAAI
hNIS imaging data from a first-in-human trial of the oncolytic virus CF33-hNIS-antiPD-L1 in patients with triple negative breast cancer
2023-04-040
PRE
Phase I study of intratumoral administration of CF33-hNIS-antiPD-L1 (CHECKvacc) in patients with metastatic triple negative breast cancer
2023-03-011
PRE